Galectin Therapeutics, Inc. (GALT)
3.64
-0.05
(-1.36%)
USD |
NASDAQ |
Oct 14, 16:00
3.62
-0.02
(-0.55%)
Pre-Market: 20:00
Galectin Therapeutics Total Long Term Debt (Quarterly) : 0.00 for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 135.71M |
| December 31, 2025 | 133.74M |
| September 30, 2025 | 32.52M |
| June 30, 2025 | 120.46M |
| March 31, 2025 | 107.92M |
| December 31, 2024 | 106.23M |
| September 30, 2024 | 104.55M |
| June 30, 2024 | 93.42M |
| March 31, 2024 | 82.46M |
| December 31, 2023 | 71.76M |
| September 30, 2023 | 61.14M |
| June 30, 2023 | 60.36M |
| March 31, 2023 | 49.94M |
| December 31, 2022 | 39.89M |
| September 30, 2022 | 29.73M |
| June 30, 2022 | 29.59M |
| March 31, 2022 | 29.28M |
| December 31, 2021 | 29.05M |
| September 30, 2021 | 19.30M |
| June 30, 2021 | 9.643M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.008M |
| September 30, 2020 | 0.019M |
| June 30, 2020 | 0.031M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.041M |
| December 31, 2019 | 0.052M |
| September 30, 2019 | 0.062M |
| June 30, 2019 | 0.072M |
| March 31, 2019 | 0.081M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Mirum Pharmaceuticals, Inc. | 760.54M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |
| Savara, Inc. | 30.11M |